Number of times cited according to CrossRef:

Joshua D. Rosenblat, Roger S. McIntyre, Pharmacological Treatment of Major Depressive Disorder, Major Depressive Disorder, 10.1016/B978-0-323-58131-8.00008-2, (103-119),

Mi kyoung Seo, Le Thi Hien, Min Kyung Park, Ah Jeong Choi, Dae-Hyun Seog, Seong-Ho Kim, Sung Woo Park, Jung Goo Lee, AMPA receptor-mTORC1 signaling activation is required for neuroplastic effects of LY341495 in rat hippocampal neurons, Scientific Reports, 10.1038/s41598-020-58017-3, 10, 1,

Natalia Gass, Robert Becker, Jonathan Reinwald, Alejandro Cosa-Linan, Markus Sack, Wolfgang Weber-Fahr, Barbara Vollmayr, Alexander Sartorius, The influence of ketamine’s repeated treatment on brain topology does not suggest an antidepressant efficacy, Translational Psychiatry, 10.1038/s41398-020-0727-8, 10, 1,

Saurabh S. Kokane, Ross J. Armant, Carlos A. Bolaños-Guzmán, Linda I. Perrotti, Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant, Behavioural Brain Research, 10.1016/j.bbr.2020.112548, (112548),

Lijia Chang, Yan Wei, Kenji Hashimoto, Antidepressant Actions of Ketamine and Its Two Enantiomers, Ketamine, 10.1007/978-981-15-2902-3, (105-125),

Dmitriy Matveychuk, Rejish K. Thomas, Jennifer Swainson, Atul Khullar, Mary-Anne MacKay, Glen B. Baker, Serdar M. Dursun, Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers, Therapeutic Advances in Psychopharmacology, 10.1177/2045125320916657, 10, (204512532091665),

Lynnette A. Averill, Samar Fouda, James W. Murrough, Chadi G. Abdallah, Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidence, , 10.1016/bs.apha.2020.04.003,

Gisèle Pickering, Bruno Pereira, Véronique Morel, Alexandrine Corriger, Fatiha Giron, Fabienne Marcaillou, Assiya Bidar-Beauvallot, Evelyne Chandeze, Céline Lambert, Lise Bernard, Noémie Delage, Ketamine and Magnesium for Refractory Neuropathic Pain, Anesthesiology, 10.1097/ALN.0000000000003345, 133, 1, (154-164),

Tanya Clark, Tara Rava Zolnikov, Climate Change and Mental Health, The Palgrave Handbook of Climate Resilient Societies, 10.1007/978-3-030-32811-5, (1-26),

Roger S McIntyre, Nelson B Rodrigues, Yena Lee, Orly Lipsitz, Mehala Subramaniapillai, Hartej Gill, Flora Nasri, Amna Majeed, Leanna M W Lui, Olena Senyk, Lee Phan, Isabelle P. Carvalho, Ashley Siegel, Rodrigo B. Mansur, Elisa Brietzke, Kevin Kratiuk, Anil K. Arekapudi, Amir Abrishami, Edmond H. Chau, Witold Szpejda, Joshua D. Rosenblat, The Effectiveness of Repeated Intravenous Ketamine on Depressive Symptoms, Suicidal Ideation and Functional Disability in Adults with Major Depressive Disorder and Bipolar Disorder: Results from the Canadian Rapid Treatment Center of Excellence, Journal of Affective Disorders, 10.1016/j.jad.2020.05.088,

Justin D. Tubbs, Jiahong Ding, Larry Baum, Pak C. Sham, Systemic neuro-dysregulation in depression: Evidence from genome-wide association, European Neuropsychopharmacology, 10.1016/j.euroneuro.2020.08.007,

Kyoung-Sae Na, Yong-Ku Kim, Increased use of ketamine for the treatment of depression: Benefits and concerns, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10.1016/j.pnpbp.2020.110060, (110060),

Nelson B. Rodrigues, Roger S. McIntyre, Orly Lipsitz, Danielle S. Cha, Yena Lee, Hartej Gill, Amna Majeed, Lee Phan, Flora Nasri, Roger Ho, Kangguang Lin, Mehala Subramaniapillai, Kevin Kratiuk, Rodrigo B. Mansur, Joshua D. Rosenblat, Changes in Symptoms of Anhedonia in Adults with Major Depressive or Bipolar Disorder Receiving IV Ketamine: Results from the Canadian Rapid Treatment Center of Excellence, Journal of Affective Disorders, 10.1016/j.jad.2020.07.083,

Roger S. McIntyre, Isabelle P. Carvalho, Leanna M.W. Lui, Amna Majeed, Prakash S. Masand, Hartej Gill, Nelson B. Rodrigues, Orly Lipsitz, Alexandria C. Coles, Yena Lee, Jocelyn K. Tamura, Michelle Iacobucci, Lee Phan, Flora Nasri, Nikhita Singhal, Elizabeth R. Wong, Mehala Subramaniapillai, Rodrigo Mansur, Roger Ho, Raymond W. Lam, Joshua D. Rosenblat, The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis, Journal of Affective Disorders, 10.1016/j.jad.2020.06.050, 276, (576-584),

Orly Lipsitz, Roger S. McIntyre, Nelson B. Rodrigues, Yena Lee, Danielle S. Cha, Hartej Gill, Mehala Subramaniapillai, Kevin Kratiuk, Kangguang Lin, Roger Ho, Rodrigo B. Mansur, Joshua D. Rosenblat, The Effectiveness of Intravenous Ketamine in Postmenopausal Women with Treatment-Resistant Depression: Results from the Canadian Rapid Treatment Center of Excellence, Journal of Psychiatric Research, 10.1016/j.jpsychires.2020.08.002,

Luke A. Jelen, Allan H. Young, The Treatment of Bipolar Depression: Current Status and Future Perspectives, Current Behavioral Neuroscience Reports, 10.1007/s40473-020-00200-x,

Yamin Yao, Peijun Ju, Hongmei Liu, Xiaohui Wu, Zhiang Niu, Yuncheng Zhu, Chen Zhang, Yiru Fang, Ifenprodil rapidly ameliorates depressive-like behaviors, activates mTOR signaling and modulates proinflammatory cytokines in the hippocampus of CUMS rats, Psychopharmacology, 10.1007/s00213-020-05469-0,

Susan Kim, Brittany S. Rush, Timothy R. Rice, A systematic review of therapeutic ketamine use in children and adolescents with treatment-resistant mood disorders, European Child & Adolescent Psychiatry, 10.1007/s00787-020-01542-3,

Yitian Yang, Yuxiang Song, Xuan Zhang, Weixing Zhao, Tao Ma, Yi Liu, Penglei Ma, Yifan Zhao, Hong Zhang, Ketamine relieves depression-like behaviors induced by chronic postsurgical pain in rats through anti-inflammatory, anti-oxidant effects and regulating BDNF expression, Psychopharmacology, 10.1007/s00213-020-05490-3,

Rachael W Taylor, Lindsey Marwood, Emanuella Oprea, Valeria DeAngel, Sarah Mather, Beatrice Valentini, Roland Zahn, Allan H Young, Anthony J Cleare, Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines, International Journal of Neuropsychopharmacology, 10.1093/ijnp/pyaa033,

Joanna Kryst, Paweł Kawalec, Alicja Mikrut Mitoraj, Andrzej Pilc, Władysław Lasoń, Tomasz Brzostek, Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials, Pharmacological Reports, 10.1007/s43440-020-00097-z,

Abhrajeet V Roy, Michelle Thai, Bonnie Klimes-Dougan, Mindy Westlund Schreiner, Bryon A Mueller, Christina Sophia Albott, Kelvin O Lim, Mark Fiecas, Susannah J Tye, Kathryn R Cullen, Brain entropy and neurotrophic molecular markers accompanying clinical improvement after ketamine: Preliminary evidence in adolescents with treatment-resistant depression, Journal of Psychopharmacology, 10.1177/0269881120928203, (026988112092820),

Michelle Thai, Zeynep Başgöze, Bonnie Klimes-Dougan, Bryon A. Mueller, Mark Fiecas, Kelvin O. Lim, C. Sophia Albott, Kathryn R. Cullen, Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression, Frontiers in Psychiatry, 10.3389/fpsyt.2020.00820, 11,

Nelson B. Rodrigues, Roger S. McIntyre, Orly Lipsitz, Yena Lee, Danielle S. Cha, Flora Nasri, Hartej Gill, Leanna M.W. Lui, Mehala Subramaniapillai, Kevin Kratiuk, Kangguang Lin, Roger Ho, Rodrigo B. Mansur, Joshua D. Rosenblat, Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence, Expert Opinion on Drug Safety, 10.1080/14740338.2020.1776699, (1-10),

Jerome Brunelin, Sylvain Iceta, Marion Plaze, Raphaël Gaillard, Louis Simon, Marie-Françoise Suaud-Chagny, Filipe Galvao, Emmanuel Poulet, The Combination of Propofol and Ketamine Does Not Enhance Clinical Responses to Electroconvulsive Therapy in Major Depression—The Results From the KEOpS Study, Frontiers in Pharmacology, 10.3389/fphar.2020.562137, 11,

Isabella P. Fallon, Margaret K. Tanner, Benjamin N. Greenwood, Michael V. Baratta, Sex differences in resilience: Experiential factors and their mechanisms, European Journal of Neuroscience, 10.1111/ejn.14639, 52, 1, (2530-2547),

Dawn F. Ionescu, Kate H. Bentley, Matthias Eikermann, Norman Taylor, Oluwaseun Johnson-Akeju, Michaela B. Swee, Kara J. Pavone, Samuel R. Petrie, Christina Dording, David Mischoulon, Jonathan E. Alpert, Emery N. Brown, Lee Baer, Matthew K. Nock, Maurizio Fava, Cristina Cusin, Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial, Journal of Affective Disorders, 10.1016/j.jad.2018.09.037, 243, (516-524),

Virginie Sterpenich, Sonia Vidal, Jeremy Hofmeister, Giorgio Michalopoulos, Victor Bancila, Delphine Warrot, Alexandre Dayer, Martin Desseilles, Jean-Michel Aubry, Markus Kosel, Sophie Schwartz, Laszlo Vutskits, Increased Reactivity of the Mesolimbic Reward System after Ketamine Injection in Patients with Treatment-resistant Major Depressive Disorder, Anesthesiology, 10.1097/ALN.0000000000002667, 130, 6, (923-935),

Jun Yamada, Shozo Jinno, Potential link between antidepressant-like effects of ketamine and promotion of adult neurogenesis in the ventral hippocampus of mice, Neuropharmacology, 10.1016/j.neuropharm.2019.107710, (107710),

Corey Tapper, Robert Arnold, Jennifer Pruskowski, Non-Oral Pharmacotherapy Options for Depression #372, Journal of Palliative Medicine, 10.1089/jpm.2019.0043, 22, 4, (454-455),

C.M. Iro, M. El Mansari, P. Blier, Repeated subanesthetic administration of ketamine maintains an increase in dopamine neurotransmission: an electrophysiological study in rat brain, European Neuropsychopharmacology, 10.1016/j.euroneuro.2018.11.1058, 29, (S78),

Lise Vlerick, Kathelijne Peremans, Robrecht Dockx, Kurt Audenaert, Chris Baeken, Jimmy H Saunders, Ingeborgh Polis, The long-term effects of single and repeated subanaesthetic ketamine administration on regional cerebral blood flow in healthy dogs measured with 99mTc-HMPAO SPECT, Psychiatry Research: Neuroimaging, 10.1016/j.pscychresns.2019.01.005,

Michel Bourin, Developing Therapies for Treatment-Resistant Depressive Disorder in Animal Models, Treatment Resistance in Psychiatry, 10.1007/978-981-10-4358-1, (79-86),

Fernanda S. Correia-Melo, Gustavo C. Leal, Flávia Vieira, Ana Paula Jesus-Nunes, Rodrigo P. Mello, Guilherme Magnavita, Ana Teresa Caliman-Fontes, Mariana V.F. Echegaray, Igor D. Bandeira, Samantha S. Silva, Diogo E. Cavalcanti, Lucas Araújo-de-Freitas, Luciana M. Sarin, Marco A. Tuena, Carolina Nakahira, Aline S. Sampaio, José A. Del-Porto, Gustavo Turecki, Colleen Loo, Acioly L.T. Lacerda, Lucas C. Quarantini, Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: a randomized, double-blind, non-inferiority study, Journal of Affective Disorders, 10.1016/j.jad.2019.11.086,

Millie Rincón-Cortés, Anthony A. Grace, Antidepressant effects of ketamine on depression-related phenotypes and dopamine dysfunction in rodent models of stress, Behavioural Brain Research, 10.1016/j.bbr.2019.112367, (112367),

Marlene P. Freeman, George I. Papakostas, Bettina Hoeppner, Erica Mazzone, Heidi Judge, Cristina Cusin, Sanjay Mathew, Gerard Sanacora, Dan Iosifescu, Charles DeBattista, Madhukar H. Trivedi, Maurizio Fava, Sex Differences in Response to Ketamine as A Rapidly Acting Intervention for Treatment Resistant Depression, Journal of Psychiatric Research, 10.1016/j.jpsychires.2019.01.010,

B. Derntl, J. Hornung, Z. D. Sen, L. Colic, M. Li, M. Walter, Interaction of Sex and Age on the Dissociative Effects of Ketamine Action in Young Healthy Participants, Frontiers in Neuroscience, 10.3389/fnins.2019.00616, 13,

Jennifer Swainson, Rejish K Thomas, Shaina Archer, Carson Chrenek, Mary-Anne MacKay, Glen Baker, Serdar Dursun, Larry J. Klassen, Pratap Chokka, Michael L Demas, Esketamine for treatment resistant depression, Expert Review of Neurotherapeutics, 10.1080/14737175.2019.1640604, (1-13),

Francis Rodriguez Bambico, Zhuoliang Li, Meaghan Creed, Danilo De Gregorio, Mustansir Diwan, Jessica Li, Sean McNeill, Gabriella Gobbi, Roger Raymond, José N Nobrega, A Key Role for Prefrontocortical Small Conductance Calcium-Activated Potassium Channels in Stress Adaptation and Rapid Antidepressant Response, Cerebral Cortex, 10.1093/cercor/bhz187,

Konstantinos N Fountoulakis, Lakshmi N Yatham, Heinz Grunze, Eduard Vieta, Allan H Young, Pierre Blier, Mauricio Tohen, Siegfried Kasper, Hans Jurgen Moeller, The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder, International Journal of Neuropsychopharmacology, 10.1093/ijnp/pyz064,

Renee-Marie Ragguett, Jocelyn K. Tamura, Roger S. McIntyre, Keeping up with the clinical advances: depression, CNS Spectrums, 10.1017/S1092852919001159, (1-9),

G.A. Mashour, A. Ben Abdallah, K.O. Pryor, R. El-Gabalawy, P.E. Vlisides, E. Jacobsohn, E. Lenze, H.R. Maybrier, R.A. Veselis, M.S. Avidan, Intraoperative ketamine for prevention of depressive symptoms after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial, British Journal of Anaesthesia, 10.1016/j.bja.2018.03.030, 121, 5, (1075-1083),

Katherine N .Wright, Mohamed Kabbaj, Sex differences in sub-anesthetic ketamine's antidepressant effects and abuse liability, Current Opinion in Behavioral Sciences, 10.1016/j.cobeha.2018.02.001, 23, (36-41),

Rejish K Thomas, Glen Baker, John Lind, Serdar Dursun, Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectiveness, Journal of Psychopharmacology, 10.1177/0269881118793104, 32, 10, (1110-1117),

Ginetta Collo, Laura Cavalleri, Cristiano Chiamulera, Emilio Merlo Pich, (2R,6R)-Hydroxynorketamine promotes dendrite outgrowth in human inducible pluripotent stem cell-derived neurons through AMPA receptor with timing and exposure compatible with ketamine infusion pharmacokinetics in humans, NeuroReport, 10.1097/WNR.0000000000001131, 29, 16, (1425-1430),

Connor Thelen, Emily Flaherty, Joseph Saurine, Jonathon Sens, Sara Mohamed, Pothitos M. Pitychoutis, Sex differences in the temporal neuromolecular and synaptogenic effects of the rapid-acting antidepressant drug ketamine in the mouse brain, Neuroscience, 10.1016/j.neuroscience.2018.11.053,

Steven P. Cohen, Anuj Bhatia, Asokumar Buvanendran, Eric S. Schwenk, Ajay D. Wasan, Robert W. Hurley, Eugene R. Viscusi, Samer Narouze, Fred N. Davis, Elspeth C. Ritchie, Timothy R. Lubenow, William M. Hooten, Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists, Regional Anesthesia and Pain Medicine, 10.1097/AAP.0000000000000808, (1),

Álvaro López-Díaz, José Luis Fernández-González, Ineffectiveness of Repeated Intravenous Ketamine Infusions in Treatment-Resistant Depression After a Post–Ketamine Relapse, Journal of Clinical Psychopharmacology, 10.1097/JCP.0000000000000933, 38, 5, (534-536),

Shaina Archer, Carson Chrenek, Jennifer Swainson, Maintenance Ketamine Therapy for Treatment-Resistant Depression, Journal of Clinical Psychopharmacology, 10.1097/JCP.0000000000000894, 38, 4, (380-384),

Kamiyu Ogyu, Kaoruhiko Kubo, Yoshihiro Noda, Yusuke Iwata, Sakiko Tsugawa, Yuki Omura, Masataka Wada, Ryosuke Tarumi, Eric Plitman, Sho Moriguchi, Takahiro Miyazaki, Hiroyuki Uchida, Ariel Graff-Guerrero, Masaru Mimura, Shinichiro Nakajima, Kynurenine pathway in depression: A systematic review and meta-analysis, Neuroscience & Biobehavioral Reviews, 10.1016/j.neubiorev.2018.03.023, 90, (16-25),

Gordon Fernie, James Currie, Jennifer S. Perrin, Caroline A. Stewart, Virginica Anderson, Daniel M. Bennett, Steven Hay, Ian C. Reid, Ketamine as the anaesthetic for electroconvulsive therapy: The KANECT randomised controlled trial, British Journal of Psychiatry, 10.1192/bjp.bp.116.189134, 210, 6, (422-428),

Roger C. M. Ho, Melvyn W. Zhang, Ketamine as a rapid antidepressant: the debate and implications, BJPsych Advances, 10.1192/apt.bp.114.014274, 22, 4, (222-233),

Hannah Zuckerman, Zihang Pan, Caroline Park, Elisa Brietzke, Natalie Musial, Aisha S. Shariq, Michelle Iacobucci, Samantha J. Yim, Leanna M. W. Lui, Carola Rong, Roger S. McIntyre, Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder, Frontiers in Psychiatry, 10.3389/fpsyt.2018.00655, 9,

Renee-Marie Ragguett, Carola Rong, Kevin Kratiuk, Roger S. McIntyre, Rapastinel - an investigational NMDA-R modulator for major depressive disorder: evidence to date, Expert Opinion on Investigational Drugs, 10.1080/13543784.2019.1559295, (1-7),

Lise Vlerick, Kathelijne Peremans, Robrecht Dockx, Kurt Audenaert, Chris Baeken, Bart De Spiegeleer, Jimmy Saunders, Ingeborgh Polis, The influence of subanaesthetic ketamine on regional cerebral blood flow in healthy dogs measured with 99mTc-HMPAO SPECT, PLOS ONE, 10.1371/journal.pone.0209316, 13, 12, (e0209316),

Francesco Angelucci, Bart A Ellenbroek, Aram El Khoury, Aleksander A. Mathé, CGRP in a gene–environment interaction model for depression: effects of antidepressant treatment, Acta Neuropsychiatrica, 10.1017/neu.2018.31, (1-7),

Brian J Mickey, Andrea T White, Anna M Arp, Kolby Leonardi, Marina M Torres, Adam L Larson, David H Odell, Sara A Whittingham, Michael M Beck, Jacob E Jessop, Derek J Sakata, Lowry A Bushnell, Matthew D Pierson, Daniela Solzbacher, E Jeremy Kendrick, Howard R Weeks, Alan R Light, Kathleen C Light, Scott C Tadler, Propofol for Treatment-Resistant Depression: A Pilot Study, International Journal of Neuropsychopharmacology, 10.1093/ijnp/pyy085,

Carola Rong, Caroline Park, Joshua Rosenblat, Mehala Subramaniapillai, Hannah Zuckerman, Dominika Fus, Yena Lee, Zihang Pan, Elisa Brietzke, Rodrigo Mansur, Danielle Cha, Leanna Lui, Roger McIntyre, Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder, International Journal of Environmental Research and Public Health, 10.3390/ijerph15040771, 15, 4, (771),

Eduardo Ekman Schenberg, Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development, Frontiers in Pharmacology, 10.3389/fphar.2018.00733, 9,

Raissa Nobrega, Kathy A Sheehy, Caroline Lippold, Amy L Rice, Julia C Finkel, Zenaide M N Quezado, Patient characteristics affect the response to ketamine and opioids during the treatment of vaso-occlusive episode-related pain in sickle cell disease, Pediatric Research, 10.1038/pr.2017.197, 83, 2, (445-454),

L Cavalleri, E Merlo Pich, M J Millan, C Chiamulera, T Kunath, P F Spano, G Collo, Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling, Molecular Psychiatry, 10.1038/mp.2017.241, 23, 4, (812-823),

Christopher James Dubey, Electroconvulsive Therapy and Brain Damage: Survey of the Evidence From a Philosophical Promontory, Ethical Human Psychology and Psychiatry, 10.1891/1559-4343.19.1.24, 19, 1, (24-50),

Frank M. Schmidt, Christian Sander, Marie-Elisa Dietz, Claudia Nowak, Thomas Schröder, Roland Mergl, Peter Schönknecht, Hubertus Himmerich, Ulrich Hegerl, Brain arousal regulation as response predictor for antidepressant therapy in major depression, Scientific Reports, 10.1038/srep45187, 7, 1,

Susana Alberich, Mónica Martínez-Cengotitabengoa, Purificación López, Iñaki Zorrilla, Nuria Núñez, Eduard Vieta, Ana González-Pinto, Efficacy and safety of ketamine in bipolar depression: A systematic review, Revista de Psiquiatría y Salud Mental (English Edition), 10.1016/j.rpsmen.2017.05.004, 10, 2, (104-112),

Mark J Niciu, Nicolas D Iadarola, Dipavo Banerjee, David A Luckenbaugh, Minkyung Park, Marc Lener, Lawrence Park, Dawn F Ionescu, Elizabeth D Ballard, Nancy E Brutsche, Nirmala Akula, Francis J McMahon, Rodrigo Machado-Vieira, Allison C Nugent, Carlos A Zarate, The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder, Journal of Psychopharmacology, 10.1177/0269881117732514, 31, 12, (1570-1577),

Steven J. Pennybaker, Mark J. Niciu, David A. Luckenbaugh, Carlos A. Zarate, Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion, Journal of Affective Disorders, 10.1016/j.jad.2016.10.026, 208, (560-566),

Gopalkumar Rakesh, Chi-Un Pae, Prakash S. Masand, Beyond serotonin: newer antidepressants in the future, Expert Review of Neurotherapeutics, 10.1080/14737175.2017.1341310, 17, 8, (777-790),

Paul Willner, The chronic mild stress (CMS) model of depression: History, evaluation and usage, Neurobiology of Stress, 10.1016/j.ynstr.2016.08.002, 6, (78-93),

Christoph Kraus, Ulrich Rabl, Thomas Vanicek, Laura Carlberg, Ana Popovic, Marie Spies, Lucie Bartova, Gregor Gryglewski, Konstantinos Papageorgiou, Rupert Lanzenberger, Matthäus Willeit, Dietmar Winkler, Janusz K. Rybakowski, Siegfried Kasper, Administration of ketamine for unipolar and bipolar depression, International Journal of Psychiatry in Clinical Practice, 10.1080/13651501.2016.1254802, 21, 1, (2-12),

B. Romeo, W. Choucha, P. Fossati, J.-Y. Rotge, Facteurs prédictifs de la réponse antidépressive à la kétamine dans les épisodes dépressifs majeurs résistants : revue de la littérature, L'Encéphale, 10.1016/j.encep.2016.06.005, 43, 4, (354-362),

Udo Bonnet, How much alcohol is in ketamine's antidepressant action?, Life Sciences, 10.1016/j.lfs.2016.11.003, 168, (54-57),

Duncan George, Verònica Gálvez, Donel Martin, Divya Kumar, John Leyden, Dusan Hadzi-Pavlovic, Simon Harper, Henry Brodaty, Paul Glue, Rohan Taylor, Philip B. Mitchell, Colleen K. Loo, Pilot Randomized Controlled Trial of Titrated Subcutaneous Ketamine in Older Patients with Treatment-Resistant Depression, The American Journal of Geriatric Psychiatry, 10.1016/j.jagp.2017.06.007, 25, 11, (1199-1209),

Janusz K. Rybakowski, Agnieszka Permoda-Osip, Alicja Bartkowska-Sniatkowska, Ketamine augmentation rapidly improves depression scores in inpatients with treatment-resistant bipolar depression, International Journal of Psychiatry in Clinical Practice, 10.1080/13651501.2017.1297834, 21, 2, (99-103),

Álvaro López-Díaz, José Luis Fernández-González, José Evaristo Luján-Jiménez, Sara Galiano-Rus, Luis Gutiérrez-Rojas, Use of repeated intravenous ketamine therapy in treatment-resistant bipolar depression with suicidal behaviour: a case report from Spain, Therapeutic Advances in Psychopharmacology, 10.1177/2045125316675578, 7, 4, (137-140),

Susana Alberich, Mónica Martínez-Cengotitabengoa, Purificación López, Iñaki Zorrilla, Nuria Núñez, Eduard Vieta, Ana González-Pinto, Eficacia y seguridad de la ketamina en depresión bipolar: una revisión sistemática, Revista de Psiquiatría y Salud Mental, 10.1016/j.rpsm.2016.05.005, 10, 2, (104-112),

Rodrigo Machado-Vieira, Ioline D. Henter, Carlos A. Zarate Jr., New targets for rapid antidepressant action, Progress in Neurobiology, 10.1016/j.pneurobio.2015.12.001, 152, (21-37),

David Feifel, Benjamin Malcolm, Danielle Boggie, Kelly Lee, Low-dose ketamine for treatment resistant depression in an academic clinical practice setting, Journal of Affective Disorders, 10.1016/j.jad.2017.06.043, 221, (283-288),

Patrick J. Morris, Ruin Moaddel, Panos Zanos, Curtis E. Moore, Todd Gould, Carlos A. Zarate, Craig J. Thomas, Synthesis and N -Methyl- d -aspartate (NMDA) Receptor Activity of Ketamine Metabolites , Organic Letters, 10.1021/acs.orglett.7b02177, 19, 17, (4572-4575),

Ioline D. Henter, Rafael T. de Sousa, Philip W. Gold, Andre R. Brunoni, Carlos A. Zarate, Rodrigo Machado-Vieira, Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression, Expert Review of Clinical Pharmacology, 10.1080/17512433.2017.1253472, 10, 2, (153-166),

Gianluca Serafini, Shawn Hayley, Mehdi Ghasemi, Mario Amore, The Role of Noncompetitive Antagonists of the N‐Methyl‐d‐aspartate (NMDA) Receptors in Treatment‐Resistant Depression, Neuroprotective Natural Products, 10.1002/9783527803781, (293-311),

Robert Schwarcz, Trevor W. Stone, The kynurenine pathway and the brain: Challenges, controversies and promises, Neuropharmacology, 10.1016/j.neuropharm.2016.08.003, 112, (237-247),

Francesco Bartoli, Ilaria Riboldi, Cristina Crocamo, Carmen Di Brita, Massimo Clerici, Giuseppe Carrà, Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis, Neuroscience & Biobehavioral Reviews, 10.1016/j.neubiorev.2017.03.010, 77, (232-236),

Yanhui Liao, Yi-lang Tang, Wei Hao, Ketamine and international regulations, The American Journal of Drug and Alcohol Abuse, 10.1080/00952990.2016.1278449, 43, 5, (495-504),

Ricardo Jorge Dinis-Oliveira, Metabolism and metabolomics of ketamine: a toxicological approach, Forensic Sciences Research, 10.1080/20961790.2017.1285219, 2, 1, (2-10),

Zurina Hassan, Oliver G. Bosch, Darshan Singh, Suresh Narayanan, B. Vicknasingam Kasinather, Erich Seifritz, Johannes Kornhuber, Boris B. Quednow, Christian P. Müller, Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs, Frontiers in Psychiatry, 10.3389/fpsyt.2017.00152, 8,

Lucia Caffino, Alessandro Piva, Giuseppe Giannotti, Marzia Di Chio, Francesca Mottarlini, Marco Venniro, David T. Yew, Cristiano Chiamulera, Fabio Fumagalli, Ketamine Self-Administration Reduces the Homeostasis of the Glutamate Synapse in the Rat Brain, Molecular Neurobiology, 10.1007/s12035-016-0231-6, 54, 9, (7186-7193),

Matthew D. Cooper, Joshua D. Rosenblat, Danielle S. Cha, Yena Lee, Ron Kakar, Roger S. McIntyre, Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review, The World Journal of Biological Psychiatry, 10.3109/15622975.2016.1139747, 18, 6, (410-423),

T. Kishimoto, J. M. Chawla, K. Hagi, C. A. Zarate, J. M. Kane, M. Bauer, C. U. Correll, Single-dose infusion ketamine and non-ketamine N -methyl- d -aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories , Psychological Medicine, 10.1017/S0033291716000064, 46, 7, (1459-1472),

Christian Otte, Stefan M. Gold, Brenda W. Penninx, Carmine M. Pariante, Amit Etkin, Maurizio Fava, David C. Mohr, Alan F. Schatzberg, Major depressive disorder, Nature Reviews Disease Primers, 10.1038/nrdp.2016.65, 2, 1,

Yu Liu, Deyong Lin, Boliang Wu, Wenhua Zhou, Ketamine abuse potential and use disorder, Brain Research Bulletin, 10.1016/j.brainresbull.2016.05.016, 126, (68-73),

Jennifer L. Vande Voort, Robert J. Morgan, Simon Kung, Keith G. Rasmussen, Jose Rico, Brian A. Palmer, Kathryn M. Schak, Susannah J. Tye, Matthew J. Ritter, Mark A. Frye, William V. Bobo, Continuation phase intravenous ketamine in adults with treatment-resistant depression, Journal of Affective Disorders, 10.1016/j.jad.2016.09.008, 206, (300-304),

Ulrich Hegerl, Christian Sander, Tilman Hensch, Arousal Regulation in Affective Disorders, Systems Neuroscience in Depression, 10.1016/B978-0-12-802456-0.00012-1, (341-370),

Peter Šóš, Is there a future for other glutamate receptor modulators in the pharmacotherapy of mood disorders?, Evidence Based Mental Health, 10.1136/eb-2015-102261, 19, 3, (95-96),

Sidney H. Kennedy, Raymond W. Lam, Roger S. McIntyre, S. Valérie Tourjman, Venkat Bhat, Pierre Blier, Mehrul Hasnain, Fabrice Jollant, Anthony J. Levitt, Glenda M. MacQueen, Shane J. McInerney, Diane McIntosh, Roumen V. Milev, Daniel J. Müller, Sagar V. Parikh, Norma L. Pearson, Arun V. Ravindran, Rudolf Uher, Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder, The Canadian Journal of Psychiatry, 10.1177/0706743716659417, 61, 9, (540-560),

Clinton Lauritsen, Santiago Mazuera, Richard B. Lipton, Sait Ashina, Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series, The Journal of Headache and Pain, 10.1186/s10194-016-0700-3, 17, 1,

Raeesah Maqsood, Trevor W. Stone, The Gut-Brain Axis, BDNF, NMDA and CNS Disorders, Neurochemical Research, 10.1007/s11064-016-2039-1, 41, 11, (2819-2835),

Connor Thelen, Jonathon Sens, Joseph Mauch, Radhika Pandit, Pothitos M. Pitychoutis, Repeated ketamine treatment induces sex-specific behavioral and neurochemical effects in mice, Behavioural Brain Research, 10.1016/j.bbr.2016.06.041, 312, (305-312),

Martin J. Lohse, Bruno Müller-Oerlinghausen, Psychopharmaka, Arzneiverordnungs-Report 2016, 10.1007/978-3-662-50351-5, (663-690),

William V. Bobo, Jennifer L. Vande Voort, Paul E. Croarkin, Jonathan G. Leung, Susannah J. Tye, Mark A. Frye, KETAMINE FOR TREATMENT‐RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE, Depression and Anxiety, 10.1002/da.22505, 33, 8, (698-710),